Physician profile
John E Walton
NPI 1376632703
$427.97
in general payments reported to CMS, 2019-2025
13 companies · $22.35 in 2025
The $22.35 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.52 · 2020: $98.28 · 2021: $82.81 · 2022: $82.23 · 2023: $88.17 · 2024: $14.61 · 2025: $22.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $98.44 | 2019-2022 | |
| Antares Pharma, INC. | $94.48 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Acerus Pharmaceuticals Corporation | $52.35 | 2020-2021 | |
| Janssen Biotech, INC. | $26.39 | 2022 | |
| Halozyme INC | $26.03 | 2023 | |
| Ambu INC. | $22.35 | 2025 | |
| Myovant Sciences INC. | $20.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.01 | 2022 | |
| Aesculap, INC. | $15.76 | 2020 | |
| Cook Medical LLC | $15.74 | 2023 | Cook |
| Travere Therapeutics, INC. | $14.13 | 2019 | |
| 180 Medical, INC. | $13.31 | 2020 | |
| Abbvie INC. | $11.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Walton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.